Cadian Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,489,055
Closed -$14.4M 29
2020
Q1
$14.4M Sell
3,489,055
-2,028,712
-37% -$8.36M 0.71% 21
2019
Q4
$26.5M Sell
5,517,767
-125,351
-2% -$603K 1.17% 23
2019
Q3
$34.2M Buy
5,643,118
+2,370
+0% +$14.4K 1.63% 18
2019
Q2
$36.6M Buy
5,640,748
+488,739
+9% +$3.17M 1.65% 20
2019
Q1
$36.5M Buy
5,152,009
+143,887
+3% +$1.02M 1.43% 19
2018
Q4
$24.3M Buy
5,008,122
+1,177,723
+31% +$5.72M 1.13% 22
2018
Q3
$28.2M Sell
3,830,399
-649,216
-14% -$4.77M 1.28% 23
2018
Q2
$28.6M Sell
4,479,615
-561,518
-11% -$3.58M 1.38% 21
2018
Q1
$27.4M Buy
5,041,133
+23,650
+0.5% +$129K 1.48% 17
2017
Q4
$20.9M Buy
5,017,483
+985,000
+24% +$4.11M 1.27% 19
2017
Q3
$38.8M Buy
4,032,483
+47,123
+1% +$454K 1.82% 18
2017
Q2
$47.1M Buy
3,985,360
+798,978
+25% +$9.45M 2.3% 16
2017
Q1
$40.8M Sell
3,186,382
-73,996
-2% -$949K 1.95% 19
2016
Q4
$39.9M Sell
3,260,378
-321,369
-9% -$3.93M 2.12% 16
2016
Q3
$42.3M Sell
3,581,747
-499,012
-12% -$5.89M 2.23% 15
2016
Q2
$35.5M Buy
4,080,759
+240,000
+6% +$2.09M 1.95% 18
2016
Q1
$20.2M Buy
3,840,759
+75,600
+2% +$398K 1.36% 22
2015
Q4
$29.2M Buy
3,765,159
+1,104,964
+42% +$8.57M 1.05% 26
2015
Q3
$20.9M Buy
2,660,195
+1,238,733
+87% +$9.75M 0.75% 39
2015
Q2
$12.9M Buy
1,421,462
+483,962
+52% +$4.38M 0.38% 48
2015
Q1
$12.2M Hold
937,500
0.33% 50
2014
Q4
$12.8M Buy
937,500
+50,000
+6% +$680K 0.32% 54
2014
Q3
$7.96M Hold
887,500
0.21% 55
2014
Q2
$12M Buy
887,500
+12,500
+1% +$169K 0.36% 49
2014
Q1
$8.7M Buy
875,000
+100,000
+13% +$994K 0.22% 52
2013
Q4
$10.3M Buy
775,000
+320,000
+70% +$4.25M 0.27% 56
2013
Q3
$5.52M Buy
+455,000
New +$5.52M 0.16% 60